BBI Life Sciences

BBI Life Sciences is a leading provider of life science research products and services, primarily operating through its flagship brand, Sangon Biotech. Headquartered in Shanghai, the company specializes in a broad range of molecular biology tools including DNA synthesis, genetic engineering services, and the production of biochemical reagents and laboratory consumables. BBI serves academic institutions, clinical laboratories, and biotechnology companies globally, facilitating fundamental research, drug discovery, and diagnostic development. Formerly listed on the Hong Kong Stock Exchange, the company was taken private in 2020 by its founding family and remains a major force in the synthetic biology and biotechnology supply chain.